IS8665A - Stöðugar samsetningar sem innihalda prostaglandín - Google Patents

Stöðugar samsetningar sem innihalda prostaglandín

Info

Publication number
IS8665A
IS8665A IS8665A IS8665A IS8665A IS 8665 A IS8665 A IS 8665A IS 8665 A IS8665 A IS 8665A IS 8665 A IS8665 A IS 8665A IS 8665 A IS8665 A IS 8665A
Authority
IS
Iceland
Prior art keywords
formulations containing
containing prostaglandin
continuous formulations
continuous
prostaglandin
Prior art date
Application number
IS8665A
Other languages
English (en)
Inventor
Deaciuc Victor
Hagan Michael
Heiati Hashem
Kostick Jette Karen
C. Visor Gregory
Gardner Cameron Mcaffer Ian
Ernest Tasko Peter
Original Assignee
Breath Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Breath Limited filed Critical Breath Limited
Publication of IS8665A publication Critical patent/IS8665A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IS8665A 2005-01-20 2007-08-02 Stöðugar samsetningar sem innihalda prostaglandín IS8665A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0501192.9A GB0501192D0 (en) 2005-01-20 2005-01-20 Stable prostaglandin-containing compositions
PCT/US2006/001626 WO2006078659A2 (en) 2005-01-20 2006-01-18 Stable prostaglandin-containing compositions

Publications (1)

Publication Number Publication Date
IS8665A true IS8665A (is) 2007-08-02

Family

ID=34259405

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8665A IS8665A (is) 2005-01-20 2007-08-02 Stöðugar samsetningar sem innihalda prostaglandín

Country Status (16)

Country Link
US (2) US8084501B2 (is)
EP (1) EP1843744A2 (is)
JP (2) JP2008528490A (is)
KR (1) KR20070094793A (is)
CN (1) CN101106973A (is)
AU (1) AU2006206649B2 (is)
BR (1) BRPI0606606A2 (is)
CA (1) CA2595237A1 (is)
CZ (1) CZ2007555A3 (is)
GB (1) GB0501192D0 (is)
IL (1) IL184111A0 (is)
IS (1) IS8665A (is)
NO (1) NO20073699L (is)
NZ (1) NZ556117A (is)
WO (1) WO2006078659A2 (is)
ZA (1) ZA200705428B (is)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI394564B (zh) * 2006-09-21 2013-05-01 Alcon Res Ltd 自行保存型水性藥學組成物
EP2094839B1 (en) 2006-12-08 2020-02-05 University of Rochester Expansion of hematopoietic stem cells
WO2008090732A1 (ja) * 2007-01-26 2008-07-31 Pola Pharma Inc. 医薬組成物
JPWO2008096804A1 (ja) * 2007-02-07 2010-05-27 テイカ製薬株式会社 ラタノプロスト含有点眼剤
JP2008247828A (ja) * 2007-03-30 2008-10-16 Wakamoto Pharmaceut Co Ltd ラタノプロストを含有する水性医薬組成物。
DK2227213T3 (da) * 2007-11-30 2013-01-02 Toltec Pharmaceuticals Llc Sammensætninger og fremgangsmåder til behandling af vaginale infektioner og patogene, vaginle biofilm
TWI544927B (zh) 2008-03-17 2016-08-11 愛爾康研究有限公司 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
EP2127638A1 (en) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
EP2328574A1 (en) * 2008-08-05 2011-06-08 University College Cork-National University of Ireland, Cork Treatment of retinal degeneration
US20100087540A1 (en) * 2008-10-07 2010-04-08 R-Tech Ueno, Ltd. Pharmaceutical composition
TW201113022A (en) * 2009-09-01 2011-04-16 R Tech Ueno Ltd Composition for ocular local-administration for treating ocular hypertension and glaucoma
US20130011354A1 (en) * 2009-11-09 2013-01-10 Allergan, Inc. Compositions For Enhancing Hair Growth
TWI478730B (zh) * 2009-12-03 2015-04-01 Alcon Res Ltd 眼科乳劑
CN103596572A (zh) * 2011-04-12 2014-02-19 株式会社·R-技术上野 水性眼用组合物
DE102011108948A1 (de) * 2011-07-29 2013-01-31 Achim Göpferich Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen
CN104208015A (zh) * 2013-05-29 2014-12-17 天津金耀集团有限公司 含有曲伏前列腺素和防腐剂的眼部制剂
EP3103439B1 (en) * 2015-06-09 2019-08-07 MEDproject Pharma-Entwicklungs- und Vertriebsgesellschaft mbH Drippable ophthalmic bimatoprost gel
KR102115285B1 (ko) * 2017-06-22 2020-05-26 연성정밀화학(주) 녹내장 치료용 점안 조성물
AU2022267568A1 (en) * 2021-04-30 2023-11-16 Innovent Biologics (Suzhou) Co., Ltd. Oxm3 storage agent, oxm3 preparation, and preparation method

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1366215A (en) * 1916-08-05 1921-01-18 Vaporackumulator Ab Supplementary power plant for electric centrals
US5165918A (en) * 1988-06-28 1992-11-24 Ciba-Geigy Corporation Antimicrobial ophthalmic solutions containing dodecyl-dimethyl-(2 phenoxyethyl)-ammonium bromide and methods of using the same
ATE114470T1 (de) * 1990-05-22 1994-12-15 R Tech Ueno Ltd Behandlung von intraocularem druck mit einer synergistischen kombination zur ophthalmischen verwendung.
CA2086874E (en) * 1992-08-03 2000-01-04 Renzo Mauro Canetta Methods for administration of taxol
US5972991A (en) * 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
AU665287B2 (en) * 1992-12-21 1995-12-21 Alcon Laboratories, Inc. Prostaglandin combinations in glaucoma therapy
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US5545665A (en) 1993-12-28 1996-08-13 Allergan Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
US5631287A (en) * 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US6011062A (en) * 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
WO1997023225A1 (en) * 1995-12-22 1997-07-03 Alcon Laboratories, Inc. Combinations of dp and fp type prostaglandins for lowering iop
AR002194A1 (es) * 1997-03-17 1998-01-07 Sanchez Reynaldo Alemany Instrumento computarizado para el analisis del movimiento.
SE9702681D0 (sv) 1997-07-10 1997-07-10 Pharmacia & Upjohn Ab Method and composition for treatment of impotence
SE9702706D0 (sv) 1997-07-11 1997-07-11 Pharmacia & Upjohn Ab Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma
WO1999012899A1 (en) 1997-09-09 1999-03-18 The Procter & Gamble Company A process for making prostaglandin f analogs
US6646001B2 (en) * 1997-12-19 2003-11-11 Alcon Manufacturing, Ltd. Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension
US6235781B1 (en) * 1998-07-14 2001-05-22 Alcon Laboratories, Inc. Prostaglandin product
US6388128B1 (en) 1998-10-05 2002-05-14 Alcon Manufacturing, Ltd. Stannane synthesis of prostanoids
US6417228B1 (en) * 1998-11-02 2002-07-09 Alcon Manufacturing, Ltd.. 13-Aza prostaglandins for the treatment of glaucoma and ocular hypertension
SE9900025D0 (sv) 1999-01-08 1999-01-08 Synphora Ab Method and composition for treatment of female sexual dysfunction
US6136846A (en) * 1999-10-25 2000-10-24 Supergen, Inc. Formulation for paclitaxel
EP1321144B1 (en) 2000-09-13 2010-12-08 Santen Pharmaceutical Co., Ltd. Eye drops
JP3876355B2 (ja) * 2000-09-13 2007-01-31 参天製薬株式会社 点眼液
AR035541A1 (es) * 2000-11-13 2004-06-16 Pharmacia Ab Un metodo de tratamiento para pacientes que sufren de glaucoma severo o necesitan una reduccion de la presion intraocular (pio) y el uso de una combinacion de agentes reductores de la pio
US6743439B1 (en) * 2001-06-27 2004-06-01 Alcon, Inc. Ophthalmic compositions containing copolymers of sulfonated styrene and maleic anhydride
US7351404B2 (en) * 2002-02-04 2008-04-01 Allergan, Inc. Method of enhancing hair growth
NO317079B1 (no) * 2002-08-02 2004-08-02 Maritime Hydraulics As Stigerorstrekkanordning
US6864282B2 (en) * 2002-08-05 2005-03-08 Allergan, Inc. 9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
US20040076678A1 (en) * 2002-08-21 2004-04-22 Sucampo Ag Opthalmic solution
EP1547599B1 (en) 2002-09-09 2017-11-01 Santen Pharmaceutical Co., Ltd. Transparent eye drops containing latanoprost
US7074827B2 (en) * 2002-10-24 2006-07-11 Sucampo Ag (Usa) Inc. Method for treating ocular hypertension and glaucoma

Also Published As

Publication number Publication date
KR20070094793A (ko) 2007-09-21
US20060270735A1 (en) 2006-11-30
WO2006078659A8 (en) 2007-08-30
IL184111A0 (en) 2007-10-31
EP1843744A2 (en) 2007-10-17
NZ556117A (en) 2009-10-30
US20120065258A1 (en) 2012-03-15
WO2006078659A2 (en) 2006-07-27
CN101106973A (zh) 2008-01-16
GB0501192D0 (en) 2005-03-02
AU2006206649B2 (en) 2010-05-27
WO2006078659A3 (en) 2006-11-16
CZ2007555A3 (cs) 2007-10-10
CA2595237A1 (en) 2006-07-27
US8084501B2 (en) 2011-12-27
AU2006206649A1 (en) 2006-07-27
NO20073699L (no) 2007-10-19
JP2013056948A (ja) 2013-03-28
ZA200705428B (en) 2008-09-25
JP2008528490A (ja) 2008-07-31
BRPI0606606A2 (pt) 2009-07-07

Similar Documents

Publication Publication Date Title
IS8665A (is) Stöðugar samsetningar sem innihalda prostaglandín
GB2424581B (en) Formulations
ZA200605354B (en) Prostaglandin nitrooxyderivatives
ATE515548T1 (de) Stabilisierte iodkohlenstoffzusammensetzungen
BRPI0613033A2 (pt) composição oral
CY2013047I1 (el) Ενωσεις διαρυλυδαντοϊνης
ITMI20041252A1 (it) Composizioni perfluoroelastomeriche
DK1812025T3 (da) Stabiliserede bakteriofagformuleringer
NO20055686D0 (no) Sammensetning
ZA200707654B (en) Formulations
EP1909584A4 (en) PRENYLFLAVONOID FORMULATIONS
DK1776090T3 (da) Stabiliseret prostaglandinsammensætning
DK2032551T3 (da) Antitumorale dihydropyran-2-on-forbindelser
DE602006018127D1 (de) Acetylenderivate
DE602006021644D1 (de) Fungizidzusammensetzungen
GB0622037D0 (en) Novel fragrance compounds
DE602005016978D1 (de) Quecksilberfreisetzende Zusammensetzungen
EP1860082A4 (en) hONEYCOMB STRUCTURE
DE502006006590D1 (de) Biozide zusammensetzungen
IL191749A0 (en) Propionamide compounds as antiinflammatory agents
ITMI20050485A1 (it) Formulazioni granulari rivestite
EP1988985A4 (en) Structured surfactant compositions
GB0517519D0 (en) Topical prostaglandin formulation
SE0500002D0 (sv) Ufo
GB0526322D0 (en) Formulations